eurofeedback for Depressio

Conditions: Depression, major depression

Registration Number: NL-OMON24001

Lead Sponsor: Prof. Dr. F.P.M.L. PeetersAfdeling PsychiatrieAcademisch Ziekenhuis MaastrichtPostbus 58006202 AZ MaastrichtTel : 043-3874130Fax : 043-3875444E-mail: f.peeters@maastrichtuniversity.nl

Brief Summary: Peeters F, Oehlen M, Ronner J, van Os J, Lousberg R (2014) Neurofeedback as a treatment for major depressive disorder--a pilot study. PLoS One 9: e91837.

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 50

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

•Primary axis-1 disorder of Major Depressive Disorder fulfilling DSM-IV criteria [14]. The diagnosis will be based on resuls from the Structured Interview for DSM-IV [15], that is an element of the diagnostic work-up at the RIAGG Maastricht.

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

•History of brain trauma (commotio or constusio cerebri) or CVA.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression severity as assessed with the Quick Inventory of Depressive Symptoms (QIDS-SR; [18], and the Hamilton Depression Rating Scale (HDRS; [19].<br /><br>•The QIDS-SR is a 16-item self-rating scale to assess symptom severity of MDD and will be administered prior to each NF session (3 times a week).<br /><br>•The HDRS is a 17-item clinician-rated scale for estimating severity of depression during the past week. It will be administered once a week by a trained research assistant during the 6-week study period.<br>

Secondary Outcome Measures